Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Dupont Buys Dyadic’s Enzyme Technology
by Melody M. Bomgardner
November 16, 2015
| A version of this story appeared in
Volume 93, Issue 45
DuPont Industrial Biosciences has agreed to buy Dyadic International’s industrial enzymes business for $75 million. Dyadic was founded in 1979 by Mark Emalfarb, now CEO. It started in the enzyme business by supplying cellulases and pumice stones for making stonewashed denim. It has since developed a fungal production platform to make industrial enzymes used in the biofuels, biobased chemicals, food, and animal health industries. In 2014, the company had revenues of $12.5 million and a loss from operations of $5.3 million. DuPont will also acquire Dyadic’s Netherlands research and development lab.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter